Market Place
Sourcing Support
CytoAgents Announces Initiation of Patient Enrollment in Phase 1b/2a Trial
17 Oct 2023 //
BUSINESSWIRE
CytoAgents receives FDA IND approval to begin trial of CRS therapy
12 May 2023 //
CLINICAL TRIALS ARENA
CytoAgents Announces FDA Acceptance of IND Application for CTO1681
11 May 2023 //
BUSINESSWIRE
CytoAgents Announces Appointment of New Chief Medical Officer
07 Sep 2022 //
BUSINESSWIRE
CytoAgents’ Ph 1 Trials Show “Cytokine Release Syndrome†Candidate`s Safe
10 Aug 2021 //
BUSINESSWIRE
CytoAgents Receives Second Round of NIH Funding to Accelerate
10 Mar 2021 //
BUSINESSWIRE
CytoAgents Receives Second Round of NIH Funding to Accelerate Treatment
10 Mar 2021 //
BUSINESSWIRE
CytoAgents Launches Clinical Trials for GP1681, Treatment of COVID-19
13 Oct 2020 //
BIOSPACE
CytoAgents Launches Clinical Trials for GP1681, Treatment of COVID-19
12 Oct 2020 //
BUSINESSWIRE
CytoAgents Receives Funding to Accelerate COVID-19 Trials for Cytokine Storm
07 Jul 2020 //
BUSINESSWIRE
CytoAgents Receives Funding to Accelerate COVID-19 Trials for Cytokine Storm
07 Jul 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.